Showing results (1-10 of 6,073) with videos related to
Sort By:
Pageof 608
Cancer|February 1, 1991
Nonseminomatous germ cell tumor with very high serum human chorionic gonadotropinJ J McKendrick, J Theaker, G M MeadClinical Oncology (Royal College of Radiologists (Great Britain))|September 11, 2002
Brain as sanctuary site of relapse in germ cell cancer patients previously treated with chemotherapyS J Crabb, J J McKendrick, G M MeadEuropean Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Prednisolone, cytosine arabinoside, lomustine (CCNU), etoposide and thioguanine (PACET) combination chemotherapy for relapsed or refractory non-Hodgkin lymphomaJ W Sweetenham, J J McKendrick, G M Mead, et al.International Journal of Oncology|January 22, 2011
The anti-leukemic effect and molecular mechanisms of novel hydroxamate and benzamide histone deacetylase inhibitors with 5-aza-cytidineH B Liu, P A Mayes, P Perlmutter, et al.British Journal of Cancer|February 1, 1990
High dose intensity combination chemotherapy for advanced epithelial ovarian carcinoma: results of a pilot studyJ W Sweetenham, J J McKendrick, D H Jones, et al.International Journal of Oncology|January 17, 2009
The anti-leukemic effect of a novel histone deacetylase inhibitor MCT-1 and 5-aza-cytidine involves augmentation of Nur77 and inhibition of MMP-9 expressionH B Liu, M T Voso, D Gumiero, et al.Anti-Cancer Drugs|June 1, 1994
Lean body mass, body surface area and epirubicin kineticsW C Cosolo, D J Morgan, E Seeman, et al.AORN Journal|February 2, 2011
Intraoperative monitoring technician: a new member of the surgical teamMolly S Brown, Debra S BrownEuropean Journal of Cancer & Clinical Oncology|March 1, 1989
ChlVPP chemotherapy in advanced Hodgkin's diseaseJ J McKendrick, G M Mead, J Sweetenham, et al.Pageof 608